Literature DB >> 32985704

ARSB gene variants causing Mucopolysaccharidosis VI in Miniature Pinscher and Miniature Schnauzer dogs.

K Raj1, L Berman-Booty1, P Foureman1, U Giger1.   

Abstract

Mucopolysaccharidosis (MPS) VI is a lysosomal storage disease caused by a deficiency of N-acetylgalactosamine-4-sulfatase, also called arylsulfatase B (ARSB, EC 3.1.6.12). Dogs with MPS VI show progressive predominantly oculoskeletal signs homologous to those in human and feline patients. We report herein two pathogenic ARSB gene variants in Miniature Pinscher and Miniature Schnauzer dogs with MPS VI and a genotyping survey in these breeds. All exons and adjacent regions of the ARSB gene were sequenced from three affected Miniature Pinschers and three affected Miniature Schnauzers. Allelic discrimination assays were used for genotyping. A missense variant (NM_001048133.1:c.910G>A) was found in exon 5 of MPS VI-affected Miniature Pinschers that is predicted to result in a deleterious amino acid substitution of a highly conserved glycine to arginine (NP_001041598.1:p.Gly304Arg). In MPS VI-affected Miniature Schnauzers, a 56 bp deletion (NM_001048133.1:c.-24_32del) was found at the junction of exon 1 and its upstream region, predicting no enzyme synthesis. All clinically affected Miniature Pinschers and Miniature Schnauzers were homozygous for the respective variants, and screened healthy dogs in each breed were either heterozygous or homozygous for the wt allele. Whereas the Miniature Pinscher variant seemed to occur commonly (0.133 allele frequency), the Miniature Schnauzer variant was presumed to be rare. In conclusion, two breed-specific pathogenic ARSB gene variants were identified in Miniature Pinscher and Miniature Schnauzer dogs with MPS VI, allowing for genotyping and informed breeding to prevent the production of affected offspring.
© 2020 Stichting International Foundation for Animal Genetics.

Entities:  

Keywords:  Maroteaux-Lamy; canine; deletion; enzyme; hereditary diseases; inborn errors of metabolism; lysosomal storage disease; missense

Mesh:

Substances:

Year:  2020        PMID: 32985704      PMCID: PMC8008615          DOI: 10.1111/age.13005

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  15 in total

1.  A comprehensive biomedical variant catalogue based on whole genome sequences of 582 dogs and eight wolves.

Authors:  V Jagannathan; C Drögemüller; T Leeb
Journal:  Anim Genet       Date:  2019-09-05       Impact factor: 3.169

2.  Two novel mutations of the arylsulfatase B gene in two Italian patients with severe form of mucopolysaccharidosis. Mutations in brief no. 127. Online.

Authors:  G R Villani; N Balzano; P Di Natale
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.

Authors:  M Evers; P Saftig; P Schmidt; A Hafner; D B McLoghlin; W Schmahl; B Hess; K von Figura; C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: A case series.

Authors:  Maurizio Scarpa; Ebba Buffone; Philipp La Marca; Mauro Campello; Angelica Rampazzo
Journal:  J Pediatr Rehabil Med       Date:  2010

5.  Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.

Authors:  A C Crawley; G Yogalingam; V J Muller; J J Hopwood
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy.

Authors:  Litsa Karageorgos; Doug A Brooks; Paul Harmatz; David Ketteridge; Anthony Pollard; Elizabeth L Melville; Emma Parkinson-Lawrence; Peter R Clements; John J Hopwood
Journal:  Mol Genet Metab       Date:  2006-12-11       Impact factor: 4.797

7.  Mucopolysaccharidosis type VI in a juvenile miniature schnauzer dog with concurrent hypertriglyceridemia, necrotizing pancreatitis, and diabetic ketoacidosis.

Authors:  Mayrim L Pérez; Heather A Kridel; Alex Gallagher; Barbara J Sheppard; Shona Reese; Hirotaka Kondo; Rick Alleman; Urs Giger
Journal:  Can Vet J       Date:  2015-03       Impact factor: 1.008

8.  Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation.

Authors:  T Kunieda; C M Simonaro; M Yoshida; H Ikadai; G Levan; R J Desnick; E H Schuchman
Journal:  Genomics       Date:  1995-10-10       Impact factor: 5.736

9.  Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.

Authors:  Ping Wang; Carol Margolis; Gloria Lin; Elizabeth L Buza; Scott Quick; Karthik Raj; Rachel Han; Urs Giger
Journal:  Vet Pathol       Date:  2017-11-20       Impact factor: 2.221

10.  Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).

Authors:  Gustavo Adolfo Giraldo; Paola Ayala-Ramírez; Juan Carlos Prieto; Reggie García-Robles; Johanna Carolina Acosta
Journal:  Meta Gene       Date:  2015-12-23
View more
  1 in total

1.  Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes.

Authors:  Maria A Ahonen; Marcus Höring; Van Dien Nguyen; Sami Qadri; Juuso H Taskinen; Meghana Nagaraj; Martin Wabitsch; Pamela Fischer-Posovszky; You Zhou; Gerhard Liebisch; P A Nidhina Haridas; Hannele Yki-Järvinen; Vesa M Olkkonen
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.